To reach the next value inflection
LicenseRx asset brief
Methods for Diagnosis of Atherosclerosis
Probability of Success
17% · grade B · Medium data confidence
Model PoS 17% (grade B, medium data confidence). Strongest signals: IP position, Modality feasibility. Biggest drag: Translational evidence.
Data maturity (22%)
43
Early / Discovery; clinical reference, biomarker readout.
IP position (16%)
88
Issued/granted patent on record.
Modality feasibility (14%)
80
Diagnostic/biomarker -- can monetize via service before full approval.
Indication pull (14%)
72
Cardiometabolic, Infectious Disease -- active buyer appetite.
Competitive whitespace (12%)
80
Under-served segment.
Translational evidence (12%)
70
Public evidence mentions: biomarker, clinical, patient.
Licensing readiness (10%)
94
Listed as available for licensing; established tech-transfer office; 1 public source link(s).
Unlock the full strategic deep dive
Cost to the next milestone, decisive data, relevant articles, and the partner-ready development plan for this asset.
View Operator access See what's included →